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Abstract Purpose: Second-gener-
ation FloTrac software has been
shown to reliably measure cardiac
output (CO) in cardiac surgical
patients. However, concerns have
been raised regarding its accuracy in
vasoplegic states. The aim of the
present multicenter study was to
investigate the accuracy of the third-
generation software in patients with
sepsis, particularly when total sys-
temic vascular resistance (TSVR) is
low. Methods: Fifty-eight septic
patients were included in this pro-
spective observational study in four
university-afﬁliated ICUs. Reference
CO was measured by bolus pulmon-
ary thermodilution (iCO) using 3–5
cold saline boluses. Simultaneously,
CO was computed from the arterial
pressure curve recorded on a com-
puter using the second-generation
(COG2) and third-generation (COG3)
FloTrac software. CO was also mea-
sured by semi-continuous pulmonary
thermodilution (CCO). Results: A
total of 401 simultaneous measure-
ments of iCO, COG2,C O G3, and CCO
were recorded. The mean (95%CI)
biases between COG2 and iCO, COG3
and iCO, and CCO and iCO were
-10 (-15 to -5)% [-0.8 (-1.1 to
-0.4) L/min], 0 (-4 to 4)% [0 (-0.3
to 0.3) L/min], and 9 (6–13)% [0.7
(0.5–1.0) L/min], respectively. The
percentage errors were 29 (20–37)%
for COG2, 30 (24–37)% for COG3,
and 28 (22–34)% for CCO. The dif-
ference between iCO and COG2 was
signiﬁcantly correlated with TSVR
(r
2 = 0.37, p\0.0001). A very weak
(r
2 = 0.05) relationship was also
observed for the difference between
iCO and COG3. Conclusions: In
patients with sepsis, the third-gener-
ation FloTrac software is more
accurate, as precise, and less inﬂu-
enced by TSVR than the second-
generation software.
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The computation of stroke volume from an arterial pres-
sure waveform is not a new concept. Proposed for the ﬁrst
time in 1904 [1], stroke volume calculation has been
improved and reﬁned by many investigators and compa-
nies over the last century. Deriving stroke volume from a
peripheral arterial pressure curve is very challenging.
Indeed, the arterial pressure waveform depends not only
on stroke volume but also on arterial compliance, vascular
tone, and reﬂection waves [2, 3]. Most methods currently
available on the market require regular manual calibration
to capture differences in arterial compliance and vascular
tone from one patient to another and in a given patient
from one time to another [2, 3]. Therefore, the accuracy of
these techniques is highly dependent on the delay between
two manual calibrations and on the hemodynamic sta-
bility of the patient [4].
A self-calibrated method has been available on the
market since 2005 (FloTrac, Edwards LifeSciences,
Irvine, CA). This method was described in detail else-
where [5]. Brieﬂy, cardiac output (CO) is computed from
the equation:
CO ¼ pulse rate   APsd   K;
whereAPsdisthestandarddeviationofarterialpressureand
J an autocalibration factor derived from a proprietary
multivariate equation. CO is updated every 20 s. This
equation includes biometric variables (e.g., age and sex,
which, according to the work of Langewouters et al. [6, 7],
are known to affect arterial compliance) and ‘‘shape vari-
ables’’ describing in mathematical or statistical terms the
shape of the arterial pressure curve. The equation was
developedfromandvalidatedinahumandatabaseofarterial
pressure tracings and thermodilution CO reference values.
The ﬁrst-generation software was developed from a
limited human database, and the multivariate equation
updated only every 10 min. Validation studies were
somewhat disappointing [8, 9]. The second-generation
software is based on a larger human database, and the
multivariate equation (i.e., J) is updated every minute
(allowing the rapid capture of acute changes in vascular
tone). The second-generation software has been shown to
be reliable in the measurement of CO, and in the tracking
of acute changes in CO but these studies were conducted
mostly in cardiac surgery patients [10–13]. Some con-
cerns have been raised regarding the second-generation
software in patients with hyperdynamic and vasoplegic
states [14–17]. A relationship (logarithmic) has been
established between FloTrac accuracy and systemic vas-
cular resistance (SVR), with FloTrac underestimating CO
when SVR is low [15, 16]. To address this limitation, a
third-generation software was recently developed from an
even larger human database, which contains a greater
proportion of hyperdynamic and vasoplegic patients.
The aim of the present multicenter study was to
investigate, in a separate cohort of patients than that used
to develop the algorithm, whether the third-generation
software is able to accurately measure CO in patients with
sepsis, particularly when SVR is low.
Materials and methods
The study was conducted in four university-afﬁliated
intensive care units (ICUs) after approval by the ethical
committee of each institution. Written informed consent
was given by all patients or their legal guardian. Patients
with sepsis [18], with a pulmonary artery catheter in place
for hemodynamic monitoring, and with a peripheral
arterial line in place for continuous blood pressure mon-
itoring were considered for the study. Patients younger
than 18 years old or less than 40 kg in weight (as this may
limit the use of continuous CO measurement with a pul-
monary artery catheter), with signiﬁcant aortic or
tricuspid valve regurgitation, or being treated with an
intra-aortic balloon pump were excluded.
Measurements
All patients had a pulmonary artery catheter connected toa
speciﬁc monitor (Vigilance, Edwards LifeSciences,Irvine,
CA, USA) for CO measurement by bolus thermodilution
(iCO) and by semi-continuous thermodilution (CCO).
Bolus measurements were obtained by using 3–5 cold
(\10C) 10 mL saline boluses (CO-Set, Edwards) ran-
domly injected throughout the respiratory cycle. The
temperature of the injectate was measured at the site of
injection. The consistency of the thermodilution curve was
judged visually on the monitor and all sets of iCO mea-
surements with a reproducibility less than 15% were
considered for analysis [19]. CCO was obtained with
automated and intermittent heating of ﬁlament wire. Five
CCO values were averaged over a 5-min period (2 CCO
values before and 3 CCO values after iCO measurements).
All patients also had a radial (n = 32) or femoral (n = 26)
arterial catheter for continuous arterial pressure monitor-
ing. Quality of damping was ensured by visualization of
oscillation decay after ﬂushing the lines. The arterial
pressure curve was recorded on a computer via a high-
ﬁdelity pressure transducer (FloTrac, Edwards Lifesci-
ences) and CO was computed off-line from the arterial
pressurecurveusingthesecond-generation(COG2,version
1.14) and the third-generation (COG3) FloTrac software.
Investigators measuring and collecting iCO values were,
therefore, blind to the FloTrac CO measurements. Fifteen
COG2 and COG3 values were averaged over a 5-min period
(7 values before and 8 values after iCO measurements).
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total SVR (TSVR) was calculated [central venous pres-
sure (CVP) was not collected] by using the equation:
TSVR ¼ MAP   80=iCO
where iCO was the reference CO for the study.
Hemodynamic measurements were performed at the
discretion of the attending physician, suggested to be at
least every 4 h during daytime whereas more measure-
ments could be obtained in case of hemodynamic
instability or to evaluate the effects of therapeutic inter-
ventions. Patients were followed for 48 h.
The study was sponsored by Edwards Lifesciences.
Computation of CO from arterial traces was performed by
Edwards Lifesciences’ technicians. The investigators had
full control of the database which was locked before
analysis. Data analysis was performed by the investigators
(DDB). The manuscript was drafted by the ﬁrst author,
and all authors reviewed the manuscript.
Statistical analysis
We used SPSS software (version 13). Results are
expressed as mean ± SD. A p\0.05 was considered
signiﬁcant. Bias was calculated as the mean difference of
COG3,C O G2, or CCO minus iCO. Limits of agreement
(LOA) were calculated as ±2SD of these differences.
Bias and LOA are presented as a percentage (absolute
values are also provided in brackets) as suggested by
Critchley and Critchley [20], because a difference
between measurements (bias) of 1 L/min, for example, is
more clinically signiﬁcant at lower than at higher COs.
The percentage error was calculated as two times the SD
of the bias over the mean iCO, as previously recom-
mended [16, 20]. A percentage error less than 30% was
considered as satisfactory [20]. The precision of the ref-
erence technique (iCO) was calculated as twice its
coefﬁcient of variability of individual bolus injections at
each iCO measurement [21]. Differences in bias were
evaluated by a Student t test with Bonferroni correction
for multiple comparisons. Differences in LOA were
evaluated with a Kolmogorov–Smirnov test [22]. The
relationships between TSVR and the differences of COG3,
COG2, or CCO minus iCO were tested for each method
using a logarithmic regression analysis.
As multiple measurements were obtained, two different
analyses were performed to limit the inﬂuence of multiple
measurements per patient. First we used a correction for
Bland and Altman analysis for multiple measurements [23,
24]. Second, as all analyses cannot be corrected by this
technique, we also present (in the ESM) an analysis con-
ducted using only the ﬁrst measurement for each patient.
Finally, we evaluated the ability of the different
techniques to track changes in CO using pairs of suc-
cessive CO measurements, with each CO measurement
used only once. For this purpose, the direction and the
amplitude of changes were evaluated [21]. Receiver
operating characteristic (ROC) curves were constructed to
evaluate the ability of each technique to detect concordant
directional changes in CO of at least 15%, with iCO used
as reference.
Results
A total of 58 patients admitted to four ICUs (Honolulu,
Hawaii, USA n = 20; Jena, Germany n = 15; Brussels,
Belgium n = 14; and Washington DC, USA n = 9) were
enrolled in the study. Patient characteristics are summa-
rized in Table 1. Hemodynamic proﬁles are provided in
Table 1 (aggregate of all measurements during the study
period) and in Table 1 in the ESM (baseline measure-
ments).Atotalof 401(6.9 ± 5.0perpatient)simultaneous
determinations of iCO, COG2,C O G3, and CCO were
available for comparison. The median time between mea-
surements was 238 (percentiles 25 and 75: 158 and
443 min, respectively) min.
Table 1 Patient characteristics
Age (years) 62 ± 14
Sex (M/F) 40/18
Weight (kg) 81 ± 24
Height (cm) 169 ± 12
Body surface area (m
2) 1.88 ± 0.25
Body mass index 28 ± 8
History of cardiac disease 25 (43%)
History of vascular disease 4 (7%)
Patient type
Medical 41 (71%)
Surgical (post-op.) 13 (22%)
Trauma 4 (7%)
Vasoactive support
Norepinephrine 39 (67%)
Vasopressin 9 (16%)
Dopamine 1 (2%)
Inotropic support
Dobutamine 16 (28%)
Milrinone 7 (12%)
Levosimendan 5 (9%)
Mechanical ventilation 51 (88%)
Hemodynamic proﬁle (aggregate measurements over the entire
study period)
Heart rate (bpm) 97 ± 19
Mean arterial pressure (mmHg) 76 ± 11
iCO (L/min) 7.5 ± 2.0
COG2 (L/min) 6.5 ± 1.5
COG3 (L/min) 7.3 ± 2.1
CCO (L/min) 8.1 ± 2.1
TSVR (dyn/(s cm
5)) 875 ± 283
TSVR total systemic vascular resistance; iCO cardiac output mea-
sured by bolus thermodilution; COG2 cardiac output measured by
second-generation FloTrac; COG3 cardiac output measured by
third-generation FloTrac; CCO cardiac output measured by semi-
continuous thermodilution
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Overall, iCO ranged from 2.7 to 14.6 L/min, COG2 from
2.5 to 14.4 L/min, COG3 from 2.5 to 17 L/min, and CCO
from 2.8 to 16 L/min. The precision of iCO was 12.4%.
The mean bias and LOA were -10 and 29% (2.2 L/min)
between COG2 and iCO, 0 and 30% (2.2 L/min) between
COG3 and iCO, and 9 and 28% (2.1 L/min) between CCO
and iCO (Fig. 1). The bias between COG3 and iCO did not
differ from 0 (0.2%, 95%CI -3.7 to 4.2%, p = 0.90) and
was signiﬁcantly less negative than the bias between COG2
and iCO (p\0.0001). Kolmogorov–Smirnov testing
showed signiﬁcant differences in the LOA between COG3
and COG2 but not between COG3 and CCO (p\0.001 and
0.59, respectively). LOA were similar when COG3 was
compared with iCO and CCO (27.2 ± 6.2% for COG3,
other data not shown). Similar results were observed when
a correction for multiple measurements per patient was not
applied (Table 2).
When only the ﬁrst measurement of CO obtained at
inclusionofthepatientwasconsidered,similarbiasandLOA
were observed (Table 2, and Fig. 1 in the ESM; hemody-
namic data are presented in Table 1 in the ESM). The bias
betweenCOG3andiCOdidnotdifferfrom0(-0.2%,95%CI
-4to?4,p = 0.90)andwassigniﬁcantlylessnegativethan
thebiasbetweenCOG2andiCO(p\0.0001).Kolmogorov–
Smirnov testing showed signiﬁcant differences in LOA
between COG3 and COG2 and between COG3 and CCO
(p\0.001 and\0.01, respectively).
Inﬂuence of TSVR on the accuracy of CO
measurements
The difference between iCO and COG2 was signiﬁcantly
correlated with TSVR (r
2 = 0.37, p\0.0001) (Fig. 2). A
very weak (r
2 = 0.05) but still statistically signiﬁcant
(p\0.0001) relationship was also observed for the dif-
ference between iCO and COG3 (Fig. 2). The difference
between iCO and CCO was not correlated with TSVR
(Fig. 2). When only one point per patient was considered,
there was no relationship between TSVR and the differ-
ences between iCO and COG3 or iCO and CCO, whereas a
signiﬁcant relationship was observed between TSVR and
the difference between iCO and COG2 (Fig. 2 in the
ESM).
Separating datapoints according to the median TSVR
value or even to extreme quartiles of TSVR showed that
the percentage errors for COG3 were similar for all TSVR
ranges explored (Table 2 in the ESM).
Detection of changes in CO measurements
The AUC of the ROC curves for detecting changes in iCO
of more than 15% in the same direction were 0.79
(0.72–0.87) for COG3, 0.78 (0.69–0.86) for COG2, 0.75
(0.66–0.84) for CCO, and 0.51 (0.42–0.62) for MAP
(Fig. 3 in the ESM). The AUCs for COG3,C O G2, and
CCO were signiﬁcantly higher than 0.5 and than MAP
(p\0.001) but there were no differences among the
different techniques. Of note, MAP was unable to detect
changes in CO in the same direction (p = 0.80). The
sensitivity, speciﬁcity, positive and negative predictive
values, positive and negative likelihood ratios, and per-
centage of correct classiﬁcation (with 95%CI) were,
Fig. 1 Bland & Altman representations of COG2,C O G3, and CCO
versus iCO. Panel a shows relation between COG2 and iCO, panel
b COG3 and iCO, and panel c CCO and iCO. The bias and limits of
agreements, computed with correction for multiple measurements
[23, 24], are provided in Table 2
236respectively, 0.78 (0.60–0.89), 0.78 (0.69–0.84), 0.50
(0.36–0.65), 0.93 (0.85–0.96), 3.5 (2.4–5.1), 0.3 (0.2–0.5),
and 0.78 (0.61–0.90) for G3; 0.76 (0.57–0.88), 0.75
(0.66–0.82), 0.44 (0.31–0.57), 0.92 (0.85–0.96), 2.9
(2.1–4.3), 0.3 (0.2–0.6), and 0.75 (0.63–0.84) for G2; and
0.72 (0.55–0.85), 0.72 (0.64–0.80), 0.43 (0.30–0.56), 0.90
(0.83–0.95), 2.6 (1.9–3.7), 0.4 (0.2–0.6), and 0.73
(0.59–0.80) for CCO.
There were no differences in the magnitude of changes
in CO detected by iCO and by the other techniques
(Table 3 in the ESM).
Inﬂuence of radial versus femoral line site
on the accuracy of CO measurements
The bias (-3.5 vs. -1.8%) and percentage error (30.4 vs.
26.6%) between COG3 and iCO were slightly greater for
radial than for femoral sites, but these differences were
not signiﬁcant (ns). Similar trends were observed for bias
(-13.4 and -11.6) and percentage errors (33.6 vs. 30.9%)
between COG2 and iCO in radial and femoral sites
(p = ns).
ThedifferencebetweeniCOandCOG3wassigniﬁcantly
correlated with TSVR at the radial site (r
2 = 0.13,
p\0.0001) but not at the femoral site (r
2 = 0.01,
p = 0.74). The difference between iCO and COG2 was
signiﬁcantly correlated with TSVR at both sites, but
the correlation was greater at the radial (r
2 = 0.51,
p\0.0001)thanatthefemoral(r
2 = 0.19,p\0.001)site.
Discussion
Our study shows that the third-generation FloTrac soft-
ware is more accurate (lower bias), as precise
(%error\30), and much less affected by SVR than the
second-generation software.
Several studies have shown that the second-generation
FloTrac is accurate (bias ranging between -0.30 to
?0.19 L/min) and precise (%error\30) compared with
thermodilution techniques [10–13]. However, other stud-
ies showed that the second-generation FloTrac may
underestimate CO in hyperdynamic and vasoplegic states
[14–17]. In patients undergoing liver transplantation, Bi-
ais et al. [15] were the ﬁrst to report a (logarithmic)
relationship between FloTrac accuracy and SVR, such
that the lower the SVR, the greater the bias between the
FloTrac value and the reference thermodilution value.
These ﬁndings were recently conﬁrmed by Biancoﬁore
et al. [16] in the same clinical setting. Our results obtained
in septic patients are in line with these ﬁndings in that we
also observed a large bias between COG2 and iCO and a
logarithmic relationship between TSVR and COG2.
It has been hypothesized that signiﬁcant gradients
between central and peripheral arterial pulse pressures
may be responsible for the underestimation of CO with
second-generation FloTrac software in patients with low
SVR. Indeed, such a gradient, likely related to a signiﬁ-
cant decrease in peripheral reﬂection waves, has been
reported in vasoplegic and/or septic states and was shown
to be reversible as soon as patients recovered [25–29].
Logically, this ‘‘decoupling’’ of aortic and radial pulse
pressure may be responsible for an underestimation of CO
when it is computed from a peripheral arterial pressure
curve. In this regard, it is important to note that all pulse
contour methods should be affected by this physiological
phenomenon. Results from several studies using different
pulse contour methods are consistent with this hypothesis.
When comparing a pulse contour method to pulmonary
thermodilution in patients with septic shock, Jellema et al.
[30] showed that the limits of agreement were almost two
times wider in patients with low SVR (\800 dyn/(s cm
5))
Table 2 Mean bias and limits of agreements (95% conﬁdence interval)
Bias % (95%CI) Percentage error % (95%CI)
All measurements (58 patients/401 measurements), without correction
G3 - iCO -2.6 (-4.1 to -1.2*
,) 29.2 (25.2–34.2)
G2 - iCO -12.4 (-14.0 to -10.8) 32.5 (26.3–36.7)
CCO - iCO 8.2 (7.0–9.5)* 25.4 (21.3–29.5)
All measurements (58 patients/401 measurements), with correction [23, 24]
G3 - iCO 0.2 (-3.7 to 4.2)*
, 30.4 (23.6–37.2)
G2 - iCO -10.3 (-15.4 to -5.3) 28.6 (20–37.2)
CCO - iCO 9.5 (5.8–13.1)* 28.0 (21.8–34.2)
First measurement only (58 patients/58 measurements)
G3 - iCO -2.6 (-6.4 to -1.1)*
, 29.2 (22.7–35.7)
G2 - iCO -12.4 (-16.6 to -8.2) 32.8 (27.5–38.1)
CCO - iCO 8.2 (5.0–11.5)* 25.6 (19.9–31.3)
iCO cardiac output measured by bolus thermodilution; COG2 car-
diac output measured by second-generation FloTrac; COG3 cardiac
output measured by third-generation FloTrac; CCO cardiac output
measured by semi-continuous thermodilution
* p\0.05 versus G2,
 p\0.05 versus CCO
237than in other patients (SVR[800 dyn/(s cm
5)). More
recently, in cardiac surgical patients, Yamashita et al. [31]
showed that when SVR was decreased dose-dependently
by prostaglandin E1 infusion, the PiCCO pulse contour
method underestimated CO by up to 40% compared with
the reference thermodilution method. The same authors
observed similar inﬂuences of vasodilation on bias and
precision between the LiDCO pulse contour method and
thermodilution [32]. Another group recently reported that
differences between femoral and radial arterial traces may
develop during patient course and generate differences in
CO up to 3.0 L/min [29]. Although we strongly suspect
that a decoupling between central and peripheral pulse
pressure may be responsible for the lack of accuracy of
pulse contour methods in vasoplegic states, evidence to
support this hypothesis is still lacking and our study was
not designed to address this issue.
Consistent with this hypothesis, we nevertheless found
that bias and percentage error tended to be higher in the
radial than the femoral site for both COG2 and COG3. This
was not related to factors speciﬁc to these patients, as bias
and percentage errors between CCO and iCO did not
differ between patients equipped with radial or femoral
lines. Even though the percentage error with COG3 using a
radial line was still acceptable in these septic patients,
femoral arterial lines should be preferred in these patients,
whenever feasible, for CO monitoring and for arterial
pressure measurements.
The new third-generation FloTrac software was
developed from a human database containing many
recordings from septic and liver transplant patients who
were often vasodilated. Some proprietary arterial pressure
waveform characteristics were identiﬁed in this subset of
patients and integrated as new ‘‘shape variables’’ in the
multivariate equation used to calculate and update J
every minute. As a result, precision has been preserved
and accuracy has been improved and is now at least as
good as that of semi-continuous pulmonary thermodilu-
tion (CCO), a method widely used and accepted in
critically ill patients.
Our study has some limitations. First, the ideal refer-
ence method for measuring CO has not been described.
However, the most commonly used technique is an
averaged set of bolus thermodilution values taken from a
pulmonary artery catheter, reported to have a precision of
10–20% [19, 20]. Ideally, we should have used a highly
reliable reference standard to make comparisons, such as
an aortic ﬂow probe applied directly to the aorta, but this
is obviously not possible in ICU patients. However, we
did optimize the precision of our thermodilution mea-
surements by using sets of measurements with a
reproducibility less than 15% [19] and using bolus ther-
modilution measurements as a reference. Moreover, we
report similar percentage error when CCO was used as an
alternative reference technique. Second, we studied
patients with sepsis-induced vasoplegia, most of them
receiving vasoactive support, with low TSVR as intended.
Whether our ﬁndings may be extrapolated to patients with
drug-induced (e.g., during anesthesia induction) or
ischemia/reperfusion-induced (e.g., post liver reperfusion
during transplantation surgery) vasoplegia remains to be
determined. One may argue that changing the algorithm
Fig. 2 Logarithmic relationships between total systemic vascular
resistance (TSVR) and the differences between COG2 and iCO,
COG3 and iCO, and CCO and iCO using all patient data.
Panel a shows relation between COG2 and iCO, panel b COG3
and iCO, and panel c CCO and iCO
238could decrease the ability of the software to measure CO
in normal or high TSVR states. Our study was not spe-
ciﬁcally designed to test this hypothesis, but several
measurements were obtained later in the patients’ course
when SVR had normalized. In these conditions, the bias
was minimal with COG3, as with previous versions, sug-
gesting that the software also performs adequately in high
and normal TSVR states. This should be conﬁrmed in
another prospective trial. Third, TSVR was computed
without CVP, inducing an overestimation of SVR of
around 15%. Of note, TSVR provides a better estimate of
arterial compliance, a key determinant of the relationship
between stroke volume and arterial waveform, than SVR
as CVP is not included in this relationship. Finally, we
used both radial and femoral arterial lines. Even though
these were mixed in the main analysis, a separate analysis
allowed us to look at the speciﬁc behavior of each cath-
eterization site, as reported above.
In conclusion, our study shows that in patients with
sepsis, the third-generation FloTrac software is more
accurate, as precise, and inﬂuenced much less by TSVR
than the second-generation software. Our data also dem-
onstrate that the overall performance of the third-
generation FloTrac is comparable to semi-continuous
pulmonary thermodilution, a technique already widely
used in septic patients.
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